Gastroenterology practices have garnered increasing interest from private equity firms over recent years, as highlighted in a May 2023 report…
Browsing: Hot headlines in GI
Skyrizi (Risankizumab) demonstrated its non-inferiority to Stelara in achieving clinical remission at 24 weeks and its superiority in endoscopic remission…
Olympus Corporation, a leading global medical technology company, has announced the market launch of its next-generation EVIS X1™ endoscopy system.…
GastroGPT, a specialty-specific artificial intelligence (AI) model tailored for gastroenterology, has shown superior performance in key clinical tasks within the…
A surprising new study has found the gender gap between male and female gastroenterologists extends to Medicare reimbursements. Based on…
A study from the Netherlands suggests that individuals aged 75 years or older, who are at the upper age limit…
A cloud-based artificial intelligence system, named Caddie, has shown significant improvements in the detection of adenomas, including those that are…
Optum’s data and analytics division experienced a 35% year-over-year revenue growth following its acquisition of Change Healthcare for $13 billion.…
COPENHAGEN, Denmark — A real-time, blood-sensing capsule (PillSense, EnteraSense Ltd) that detects upper gastrointestinal bleeding (UGIB) is safe and effective…
CHICAGO—On average, surgeons are much less likely than gastroenterologists to detect adenomas during routine screening colonoscopy, according to a VA…